BioSpace News Archive

Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder

Avicanna is pleased to announce the completion of its second non-brokered private placement offering for units in Avicanna.

January 29, 2018
·
4 min read
LimFlow Completes Enrollment In U.S. Feasibility Study and Receives Breakthrough Device Status from FDA for Its Percutaneous Deep Vein Arterialization (pDVA) System

LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), today announced completion of enrollment of the original 10-patient cohort in the U.S. feasibility study of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System.

January 29, 2018
·
3 min read
Drug Development

Tetra Bio-Pharma Receives Health Canada Approval for Phase 2 Cannabis Oil Trial in Partnership with Sante Cannabis

Tetra Bio-Pharma announce the approval by Health Canada of a Phase 2 clinical trial designed to evaluate the safety and efficacy of different doses and ratios of medical cannabis oil (THC & CBD) to improve uncontrolled chronic pain in cancer and non-cancer patients.

January 29, 2018
·
6 min read
Pharm Country

ISS Recommends Aviragen Stockholders Vote AGAINST the Vaxart Merger on the CAS Group’s BLUE Proxy Card

In reaching its conclusion, ISS performed a detailed review of both sides’ positions in the election contest as well as its own thorough independent analysis.

January 29, 2018
·
9 min read
Genetown

Innovation Pharmaceuticals Brilacidin Franchise Anchored in Three Clinical Indications — Oral Mucositis, Inflammatory Bowel Disease and Serious Skin Infections; Expands into Dermatologic Diseases

The company gave a business update today.

January 29, 2018
·
6 min read
BioCapital

Rexahn Pharmaceuticals Receives Notice of Allowance for A New U.S. Patent Covering the Use of RX-5902 (Supinoxin)

The allowed application will extend the patent protection for uses claimed under this patent until 2036.

January 29, 2018
·
6 min read
Policy

Mylan and Biocon Receive Positive CHMP Opinion for Semglee, Biosimilar Insulin Glargine

The CHMP positive opinion will be considered by the European Commission. The European Commission decision on the approval is expected in April.

January 29, 2018
·
7 min read
Drug Development

Prometic’s PBI-4050: Phase III Pivotal Clinical Trial Design for Idiopathic Pulmonary Fibrosis (IPF) Finalized

ProMetic Life Sciences announces today the outcome of a successful clinical development Type C meeting with the FDA for its orally active anti-fibrotic lead drug candidate, PBI-4050.

January 29, 2018
·
7 min read
Pharm Country

Egalet Announces ARYMO ER Data Published in Current Medical Research and Opinion Journal

ARYMO ER is approved for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

January 29, 2018
·
18 min read
NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project

In an experimental study carried out in collaboration with researchers at Karolinska Instutet in Stockholm, Sweden, the project’s model substance has shown favourable effects which may counter disease progression in mitochondrial myopathy.

January 29, 2018
·
5 min read